Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16

Cancer

Volumn 104, Issue 5, 2005, Pages 1037-1044

  Matsuda, Yasunobu ^a   Yamagiwa, Satoshi ^a   Takamura, Masaaki ^a   Honda, Yutaka ^a   Ishimoto, Yuiko ^a   Ichida, Takafumi ^b   Aoyagi, Yutaka ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Id 1; p16

Indexed keywords

DNA BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION DNA BINDING PROTEIN 1; PROTEIN P16; TRANSCRIPTION FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPRESSOR PROTEINS; RISK; TRANSCRIPTION FACTORS;

EID: 23844556529     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21259     Document Type: Article

References (39)

1. Taran K, Shimizu A, Harada M, et al. Difference in the in vitro uptake of bromodeoxyuridine between liver cirrhosis with and without hepatocellular carcinoma. Cancer. 1989; 64:104-109.
2. Derenzini M, Trerè D, Oliveri F, et al. Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease? J Clin Pathol. 1993;40:727-729.
3. Tarao K, Ohkawa S, Shimizu A, et al. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer. 1994;73:1149-1154.
4. Ballardini O, Groff P, Zoli M, et al. Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation. J Hepatol. 1994; 20:218-222.
5. Shibata M, Morizane T, Uchida T, et al. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet. 1998;351:1773-1777.
6. Borzio M, Trerè D, Borzio F, et al. Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis. Mol Pathol. 1998; 51:96-101.
7. Donato M, Arosio E, Del Ninno E, et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology. 2001;34:523-528.
8. Sangiovanni A, Colombo E, Radaelli F, et al. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients. Am J Gastroenterol. 2001;96:1575-1580.
9. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 1990;61:49-59.
10. Israel MA, Hernandez MC, Florio M, et al. Id gene expression as a key mediator of tumor cell biology. Cancer Res. 1999;59(Suppl):1726s-1730s.
11. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad Sci USA. 1999;96:9637-9641.
12. Norton JD, Deed RW, Craggs G, Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 1998;8:58-65.
13. Maruyama H, Kleeff J, Wildi S, et al. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol. 1999;155:815-822.
14. Ohtani N, Zebedee Z, Huot TJ, et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 2001;409:1067-1070.
15. Hui AM, Sakamoto M, Kanai Y, et al. Inactivation of p16(INK4) in hepatocellular carcinoma. Hepatology. 1996; 24:575-579.
16. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H. p16 (INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology. 1999; 116:394-400.
17. Tannapfel A, Busse C, Weinans L, et al. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene. 2001;20:7104-7109.
18. Dorai H, Sampath TK. Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture. J Bone Joint Surg Am. 2001;83-A(Suppl 1):S70-78.
19. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 2001;61:5703-5706.
20. Schindl M, Schoppmann SF, Strobel T, et al. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res. 2003; 9:779-785.
21. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996; 93:9821-9826.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958;53:457-481.
23. Uehara N, Chou YC, Galvez JJ, et al. Id-1 is not expressed in the luminal epithelial cells of mammary glands. Breast cancer Res. 2003;5:R25-R29.
24. Kang YK, Kim CJ, Kim WH, Kim HO, Kang GH, Kim YI. P53 mutation and overexpression in hepatocellular carcinoma and dysplastic nodules in the liver. Virchows Arch. 1998;432: 27-32.
25. Choi YL, Park SH, Jang JJ, Park CK. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma. J Korean Med Sci. 2001;16:424-432.
26. Wagayama H, Shiraki K, Sugimoto K, et al. High expression of p21 (WAF1/CIP1) is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases. Hum Pathol. 2002;33:429-434.
27. Hara E, Yamaguchi T, Nojima H, et al. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem. 1994;269:2139-2145.
28. Alani RM, Young AZ, Snifflett CB. Id-1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci. USA. 2001;98:7812-7816.
29. Ohtani N, Zebedee Z, Huot T, et al. Opposing effects of Ets and Id proteins on p16Ink4a expression during cellular senescence. Nature. 2001;409:1067-1070.
30. Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW, Wong YC. Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis. 2002;23:721-725.
31. Prabhu S, Ignatova A, Park ST, Sun XU. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol Cell Biol. 1997;17:5888-5896.
32. Pagliuca A, Gallo P, De Luca P, Lania L. Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res. 2000;60:1376-1382.
33. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 2001;61:5703-5706.
34. Schoppmann SF, Schindl M, Bayer G, et al. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer. 2003;104:677-682.
35. Kaneto H, Sasaki S, Yamamoto H, et al. Detection of hypermethylation of the p16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut. 2001;48:372-377.
36. Lee TK, Man K, Ling MT, et al. Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway. Carcinogenesis. 2003;24:1729-1736.
37. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;43:461-466.
38. Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285-296.
39. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC. Id-1 expression promotes cell survival through activation of NF-κB signalling pathway in prostate cancer cells. Oncogene. 2003;22:4498-4508.